Page 124 - Biomedical Engineering and Design Handbook Volume 2, Applications
P. 124

OVERVIEW OF CARDIOVASCULAR DEVICES  103

                          Graziani, L. J., M. Gringtas, et al. (1997). “Cerebrovascular complications and neurodevelopmental sequelae of
                            neonatal ECMO.” Clin Perinatol, 24(3):655–75.
                          Gregoratos, G., M. D. Cheitlin, et al. (1998). “ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and
                            Antiarrhythmia Devices: Executive Summary—a report of the American College of Cardiology/American
                            Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).” Circulation,
                            97(13):1325–35.
                          Greisler, H. P. (1991).  New Biologic and Synthetic  Vascular Prostheses.  Austin,  TX, U.S.A., R.G. Landes
                            Biosciences Co.
                          Greisler, H. P. (1996). “Growth factor release from vascular grafts.” J Control Release, 39(2–3):287–280.
                          Grooteman, M. P. and M. J. Nube (1998). “Haemodialysis-related bioincompatibility: fundamental aspects and
                            clinical relevance.” Neth J Med, 52(5):169–78.
                          Grube, E., J. C. Laborde, et al. (2005). “First report on a human percutaneous transluminal implantation of a self-
                            expanding valve prosthesis for interventional treatment of aortic valve stenosis.” Catheter Cardiovasc Interv,
                            66(4):465–9.
                          Gu, Y. J., P. W. Boonstra, et al. (1998). “Cardiopulmonary bypass circuit treated with surface-modifying addi-
                            tives: a clinical evaluation of blood compatibility.” Ann Thorac Surg, 65(5):1342–7.
                          Gulbins, H., A. Pritisanac, et al. (2006). “Successful endothelialization of porcine glutaraldehyde-fixed aortic
                            valves in a heterotopic sheep model.” Ann Thorac Surg, 81(4):1472–9.
                          Hakim, R. M. and J. M. Lazarus (1995). “Initiation of dialysis.” J Am Soc Nephrol, 6(5):1319–28.
                          Hammermeister, K., G. K. Sethi, et al. (2000). “Outcomes 15 years after valve replacement with a mechanical
                            versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial.”  J  Am Coll Cardiol,
                            36(4):1152–8.
                          Harris, L. M. (2005). Chapter 48: The modified biograft. Vascular Surgery. R. B. Rutherford, Philadelphia, PA,
                            U.S.A., Elsevier Saunders. V1.
                          Hasaniya, N. W., M. Angelis, et al. (1996). “Efficacy of subcutaneous silver-impregnated cuffs in preventing cen-
                            tral venous catheter infections.” Chest, 109(4):1030–2.
                          Heath, M. J. and M. L. Dickstein (2000). “Perioperative management of the left ventricular assist device recipient.”
                            Prog Cardiovasc Dis, 43(1):47–54.
                          Helmus, M. N. and J. A. Hubbell (1993). “Materials Selection.” Cardiovasc Pathol, 2(3 Suppl 1):53–71.
                          Henry, M., C. Klonaris, et al (2000). “State of the art: which stent for which lesion in peripheral interventions?”
                            Tex Heart Inst J, 27(2):119–26.
                          Hirsch, A. T., Z. J. Haskal, et al. (2006). “ACC/AHA 2005 Practice Guidelines for the management of patients
                            with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative
                            report from the  American  Association for  Vascular Surgery/Society for  Vascular Surgery, Society for
                            Cardiovascular  Angiography and Interventions, Society for  Vascular Medicine and Biology, Society of
                            Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to
                            Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the
                            American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood
                            Institute; Society for  Vascular Nursing;  TransAtlantic Inter-Society Consensus; and  Vascular Disease
                            Foundation.” Circulation, 113(11):e463–654.
                          Hoggard, J., T. Saad, et al. (2008). “Guidelines for venous access in patients with chronic kidney disease.” Semin
                            Dial, 21(2):186–91.
                          Holman, W. L., J. L. Skinner, et al. (1999). “Infection during circulatory support with ventricular assist devices.”
                            Ann Thorac Surg, 68(2):711–6.
                          Holmes, D. R., Jr., J. Hirshfeld, Jr., et al. (1998). “ACC Expert Consensus document on coronary artery stents.
                            Document of the American College of Cardiology.” J Am Coll Cardiol, 32(5):1471–82.
                          Horstkotte, D. (1996). “Results with mechanical cardiac valvular prostheses [Letter].” Ann Thorac Surg, 62(5):1565–7.
                          Hoshal, V. L., Jr., R. G. Ause, et al. (1971). “Fibrin sleeve formation on indwelling subclavian central venous
                            catheters.” Arch Surg, 102(4):253–8.
                          Humes, H. D., W. H. Fissell, et al. (2002a). “The bioartificial kidney in the treatment of acute renal failure.”
                            Kidney Int, 61(Suppl 80):S121–5.
                          Humes, H. D., W. H. Fisseli, et al. (2002b). “Metabolic replacement of kidney function in uremic animals with
                            a bioartificial kidney containing human cells.” Am J Kidney Dis, 39(5):1078–87.
   119   120   121   122   123   124   125   126   127   128   129